Table 1.
Patient Characteristics by Race/Ethnicity
| Non-Hispanic White | Black | Hispanic | Other | P Value | |
|---|---|---|---|---|---|
| N (%) or median (interquartile range) | |||||
| N | 3926 | 1286 | 1837 | 667 | |
| Deprivation Index | 0.34 (0.28–0.41) | 0.44 (0.36–0.52) | 0.44 (0.36–0.53) | 0.34 (0.27–0.44) | <0.001 |
| Insurance | |||||
| Private | 2372 (60) | 356 (28) | 423 (23) | 347 (52) | <0.001 |
| Public | 1439 (37) | 908 (71) | 1378 (75) | 308 (46) | |
| Other | 113 (3) | 21 (2) | 36 (2) | 12 (2) | |
| Female gender | 1938 (49) | 670 (52) | 935 (51) | 336 (50) | 0.35 |
| Diagnosis | |||||
| Biliary atresia | 1031 (26) | 388 (30) | 470 (26) | 233 (35) | <0.001 |
| Cholestatic liver disease | 925 (24) | 291 (23) | 377 (21) | 116 (17) | |
| Acute liver failure | 402 (10) | 161 (13) | 324 (18) | 72 (11) | |
| Metabolic | 387 (10) | 65 (5) | 152 (8) | 56 (8) | |
| Tumor | 325 (8) | 53 (4) | 151 (8) | 49 (7) | |
| Autoimmune hepatitis | 198 (5) | 84 (7) | 64 (4) | 19 (3) | |
| Other | 658 (17) | 244 (19) | 299 (16) | 122 (18) | |
| Living donor transplant | 3558 (91) | 1214 (94) | 1726 (94) | 616 (92) | <0.001 |
| Time on waitlist (days) | 62 (13–203) | 65 (15–211) | 59 (12–190) | 54 (15–167) | 0.35 |
| Initial Status 1A/1B listing | 772 (20) | 249 (19) | 421 (23) | 140 (21) | 0.03 |
| Status 1A/1B at time of transplant | 1089 (28) | 310 (24) | 549 (30) | 195 (29) | 0.004 |
| Status 1A/1B at any time | 1234 (31) | 355 (28) | 648 (35) | 225 (34) | |
| Initial lab PELD/MELD | 13 (2–22) | 17 (8–25) | 15 (4–24) | 15 (5–25) | <0.001 |
| Final lab PELD/MELD | 13 (3–24) | 17 (7–25) | 15 (3–26) | 16 (5–27) | <0.001 |
| Initial allocation PELD/MELD | 15 (6–27) | 17 (10–27) | 16 (6–28) | 15.5 (7–28) | <0.001 |
| Final allocation PELD/MELD | 26 (16–34) | 24 (16–33) | 27 (16–33) | 25 (15–35) | 0.48 |
| Initial lab PELD/MELD quartile | |||||
| 1 | 1140 (29) | 230 (18) | 479 (26) | 166 (25) | <0.001 |
| 2 | 1003 (26) | 314 (24) | 426 (23) | 158 (24) | |
| 3 | 922 (24) | 380 (30) | 423 (23) | 160 (24) | |
| 4 | 860 (22) | 362 (28) | 509 (28) | 183 (27) | |
| Ascites | 562 (18) | 170 (16) | 300 (21) | 92 (17) | 0.01 |
| Encephalopathy | 264 (8.5%) | 109 (10.2%) | 172 (11.8%) | 50 (9.4%) | 0.01 |
| Waitlist outcome | |||||
| Censored | 65 (2) | 23 (2) | 49 (3) | 11 (2) | <0.001 |
| Death | 213 (5) | 100 (8) | 126 (7) | 37 (5) | |
| Too Sick | 119 (3) | 48 (4) | 93 (5) | 40 (6) | |
| DDLT | 2635 (67) | 870 (68) | 1182 (64) | 441 (66) | |
| Other removal | 526 (13) | 173 (14) | 276 (15) | 87 (13) | |
| LDLT | 368 (9) | 72 (6) | 111 (6) | 51 (8) | |
Abbreviations: DDLT, Deceased donor liver transplant; IQR, Interquartile range; LDLT, Living donor liver transplant; MELD, Model for End-Stage Liver Disease; PELD, Pediatric End-Stage Liver Disease